The iconic status of Viagra, and its parent corporation copyright, presents a challenging question for investors . While earnings initially soared , the looming patent lapse and rising generic competition https://lillihknw320270.dreamyblogs.com/41827306/the-blue-pill-and-big-pharma-a-speculative-investment